Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer | Zendy

Glockzin Gabriel | Zendy; Ghali Nabil | Zendy; Lang Sven A. | Zendy; Schlitt Hans J. | Zendy; Piso Pompiliu | Zendy

Premium

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer

Author(s) -

Glockzin Gabriel,

Ghali Nabil,

Lang Sven A.,

Schlitt Hans J.,

Piso Pompiliu

Publication year - 2009

Publication title -

journal of surgical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.201

H-Index - 111

eISSN - 1096-9098

pISSN - 0022-4790

DOI - 10.1002/jso.21332

Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , cytoreductive surgery , peritoneal carcinomatosis , colorectal cancer , intraperitoneal chemotherapy , chemotherapy , surgery , cancer , oncology , ovarian cancer

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for selected patients with peritoneal carcinomatosis arising from colorectal cancer. Due to the aggressive surgery the concept is associated with a significant morbidity rate. Thus, the operative risk has to be evaluated against the background of the expected improvement of the oncological outcome. J. Surg. Oncol. 2009;100:306–310. © 2009 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research